CoChat

Aloe emodin disrupts Candida albicans mitochondrial iron homeostasis against its hyphal development and oral candidiasis

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index; 9 of the 23 sources its claims cite were checked for support.

Abstract

Candida albicans , a critical pathogen listed on the WHO fungal priority pathogens list, is a major cause of candidiasis and candidemia, particularly in immunocompromised populations. The lack of novel antifungal drugs and the increasing prevalence of drug resistance underscore the urgent need for new therapeutic strategies. By screening compounds derived from Aloe vera using hyphal induction assays, we identified aloe emodin (AE) as a potent inhibitor of C. albicans hyphal development. We demonstrate for the first time that AE, at concentrations of 50–100 μg/mL that do not affect fungal growth, significantly inhibits C. albicans hyphal development and its infections to oral epithelial cells without cytotoxicity. The confocal observation and following transcriptome and metabolome analysis demonstrate that AE localizes to fungal mitochondria and chelates iron, thereby disrupting iron homeostasis. These effects lead to mitochondrial dysfunction and metabolic reprogramming, particularly by impairing succinate dehydrogenase 2 activity, thereby reducing ATP and cAMP production. The decrease in cAMP levels leads to downregulation of the cAMP–PKA signaling pathway, a central regulator of hyphal development, ultimately suppressing hyphal growth. Mitochondrial function and metabolic assays, together with validation using mutants of the cAMP–PKA pathway, further confirmed the mechanism underlying the anti-hyphal activity of AE. AE at 50–100 μg/mL administered via drinking water also significantly reduced fungal burden and tissue damage in an oropharyngeal candidiasis model, which is similar with clinical antifungal nystatin. Collectively, our findings indicate that AE is a promising candidate for development as a therapeutic agent for oral candidiasis. Key points: • Aloe emodin disrupts mitochondrial iron homeostasis to remodel metabolism in C. albicans. • Aloe emodin downregulates the cAMP-PKA pathway to inhibit C. albicans hyphae. • Aloe emodin functions as a novel candidate for treating infections caused by C. albicans. Graphical Abstract:

Overview

CoChat Summary

TL;DR

Aloe emodin (AE) inhibits Candida albicans hyphal development and oral candidiasis without directly blocking fungal growth. It localizes to mitochondria, disrupts mitochondrial iron homeostasis, reduces SDH activity and ATP/cAMP, and downregulates the cAMP–PKA pathway.

Key findings

  • AE at 50–100 μg/mL significantly inhibited C. albicans hyphal formation in liquid medium and on Spider agar, reduced hyphal length, and suppressed hyphal formation in all 11 clinical isolates tested, while showing no inhibitory effect on fungal growth.
  • AE reduced C. albicans–induced damage to human oral keratinocyte cells, decreased fungal invasion, and enhanced macrophage phagocytic uptake; it did not affect fungal adhesion and showed no cytotoxicity toward HOK cells at 50 and 100 μg/mL.
  • Mechanistically, AE colocalized with mitochondria, dose-dependently reduced mitochondrial iron content and mitochondrial membrane potential, decreased SDH activity, and lowered intracellular ATP and cAMP; it downregulated RAS1, TPK1, and TPK2, while ras1Δ/Δ, cyr1Δ/Δ, tpk1Δ/Δ, and tpk2Δ/Δ mutants enhanced AE inhibition and RAS1 overexpression attenuated it.
  • In a murine oral candidiasis model, AE at 50 or 100 μg/mL in drinking water reduced tongue plaques, fungal burden, inflammatory cell infiltration, and hyphal invasion comparably to nystatin (100,000 IU/kg), with no obvious histopathological abnormalities in liver or kidney.

Methods

  • In vitro assays used C. albicans SC5314, 11 clinical isolates, cAMP–PKA mutants (ras1Δ/Δ, cyr1Δ/Δ, tpk1Δ/Δ, tpk2Δ/Δ), and RAS1/SDH2 overexpression strains; hyphal formation, growth curves, cytotoxicity, adhesion, invasion, LDH damage, and macrophage susceptibility were measured.
  • Transcriptomic analysis was performed after 100 μg/mL AE treatment for 6 and 12 h, and metabolomic analysis after 3 and 6 h; WGCNA, GO/KEGG enrichment, qRT-PCR, JC-1 MMP staining, Mito-FerroGreen mitochondrial iron measurement, SDH activity, and ATP/cAMP assays were used.
  • In vivo, female BALB/c mice (4–6 weeks old) were sublingually infected with 1 × 10^7 CFU/mL C. albicans and given AE (50 or 100 μg/mL) or nystatin (100,000 IU/kg) in drinking water; tongues were harvested 4 days after infection for fungal burden and histopathology.

Limitations

  • Stated: the authors cannot exclude that iron dyshomeostasis is also a secondary consequence of mitochondrial dysfunction; AE likely affects multiple interconnected targets; further studies are needed to assess safety, pharmacokinetics, clinical applicability, and the integrated regulatory pathways.
  • Evident from the text: in vivo evaluation used a single mouse oral candidiasis model with a 4-day endpoint, and systemic safety was assessed mainly by liver and kidney histology rather than comprehensive toxicology or pharmacokinetic analysis.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00253-026-13740-1

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC BY · From the PDF
Image 2
CC BY · From the PDF
Image 3
CC BY · From the PDF
Image 4
CC BY · From the PDF
Image 5
CC BY · From the PDF
Image 6
CC BY · From the PDF
Image 7
CC BY · From the PDF

Verification

Claims the paper makes

9 Valid · 0 Not valid · 10 Not checked · 71 Own results and interpretations

56 more claims

Create a free account to see all 90 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 7
  • It may state two separate claims as one. 19
  • The quote only partly states this claim. 5

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Cited by

See all 1

Metadata

Authors
Shen, J., Zhang, C., Lin, Y., Zhang, C., Zhou, J., Zhou, Y., Gou, L., Liao, G., Zhu, Z., Cheng, L., Liao, B., & Ren, B.
Affiliations
  • Sichuan University (CN)
  • Beijing University of Chinese Medicine (CN)
  • Sun Yat-sen University (CN)
Corresponding author
  • Liao, Binyou
  • Ren, Biao
Venue
Applied Microbiology and Biotechnology
Published
2026-02-20
Volume
110
Issue
1
ISSN
  • 0175-7598 (ISSN-L)
  • 1432-0614
OpenAlex
W7130661898
Cited by
0
References
52
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
Locations
  • Applied Microbiology and Biotechnology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Sichuan Provincial Health Committee Research Grant (150115)
  • National Natural Science Foundation of China (82401116, 32470205)
  • Fund of the State Key Laboratory of Oral Diseases (SKLOD-2025RD008)
  • Research and Develop Program, West China Hospital of Stomatology, Sichuan University (RCDWJS2024-(2))
  • Natural Science Foundation of Sichuan province (2024NSFSC0546)
  • Technology Innovation R&D Project of Chengdu (2022-YF05-01415-SN)
  • Health Commission of Sichuan Province (chuanganyan 2024-901)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry and biological activity of medicinal plants
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
aloe-emodin, Candida albicans, oral candidiasis, hyphal development, mitochondrial iron homeostasis, iron chelation, cAMP/PKA signaling, mitochondrial dysfunction, metabolic reprogramming, antifungal agents, oropharyngeal candidiasis
MeSH terms
Cyclic AMP, Animals, Anthraquinones, Antifungal Agents, Candida albicans, Candidiasis, Oral, Epithelial Cells, Homeostasis, Humans, Iron, Mitochondria, Signal Transduction, Hyphae

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.